Independent minds. Global perspective. A publication for the builders
Biotechnology / Galway, Ireland

Alison Liddy.

Founder
Relevium Medical

Alison Liddy is a founder of Relevium Medical, which develops injectable treatments for knee osteoarthritis. Her background combines chemistry, biochemical engineering and experience at medical technology companies including Roche, Cook Medical and Boston Scientific. She also completed the BioInnovate fellowship in Galway, connecting technical training with a programme centred on identifying healthcare needs.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Alison Liddy and the story of Relevium Medical.

Relevium's public materials describe work on drug delivery within a knee joint, including a more recent account of a capsaicin formulation called RM-010. Earlier launch material describes a different therapeutic approach. These accounts show the company's development focus and its interest in fitting a treatment into existing clinical workflows. They do not, by themselves, establish regulatory approval, clinical safety or patient benefit, and no treatment recommendation is inferred from them.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Relevium Medical — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗